These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. KRAS Oncoprotein Expression Is Regulated by a Self-Governing eIF5A-PEAK1 Feed-Forward Regulatory Loop. Fujimura K; Wang H; Watson F; Klemke RL Cancer Res; 2018 Mar; 78(6):1444-1456. PubMed ID: 29321164 [TBL] [Abstract][Full Text] [Related]
8. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells. Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis-A connection to licensing nodes. Schneeweis C; Wirth M; Saur D; Reichert M; Schneider G Small GTPases; 2018 Nov; 9(6):457-464. PubMed ID: 27880072 [TBL] [Abstract][Full Text] [Related]
10. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16. Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115 [TBL] [Abstract][Full Text] [Related]
12. Critical role of oncogenic KRAS in pancreatic cancer (Review). Liu J; Ji S; Liang C; Qin Y; Jin K; Liang D; Xu W; Shi S; Zhang B; Liu L; Liu C; Xu J; Ni Q; Yu X Mol Med Rep; 2016 Jun; 13(6):4943-9. PubMed ID: 27121414 [TBL] [Abstract][Full Text] [Related]
13. p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation. Wang K; Baldwin GS; Nikfarjam M; He H World J Gastroenterol; 2018 Sep; 24(33):3709-3723. PubMed ID: 30197477 [TBL] [Abstract][Full Text] [Related]
14. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677 [TBL] [Abstract][Full Text] [Related]
15. RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer. Kang R; Hou W; Zhang Q; Chen R; Lee YJ; Bartlett DL; Lotze MT; Tang D; Zeh HJ Cell Death Dis; 2014 Oct; 5(10):e1480. PubMed ID: 25341034 [TBL] [Abstract][Full Text] [Related]